Galena Biopharma to Present at the Rodman & Renshaw Annual Global Investment Conference

Galena Biopharma, Inc.

PORTLAND, Ore., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company commercializing and developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President & Chief Executive Officer, will present a corporate update at the Rodman & Renshaw Annual Global Investment Conference. The presentation will take place on Monday, September 9, 2013 at 10:25 a.m. ET at the Millennium Broadway Hotel in New York, NY.

The presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company commercializing and developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com.

CONTACT: Remy Bernarda Senior Director, Communications (503) 405-8258 rbernarda@galenabiopharma.com

Source:Galena Biopharma